Worth noting, as mentioned in the ann, cash in this quarter, costs out next quarter. So the next quarterly will show a substantial raise in the cash balance. Perhaps some hype and pump around that will be the trigger for the cap raise before the ~$4m in costs of this $4.2m received get paid.
- Forums
- ASX - By Stock
- Ann: Defence Contract - $4.2m Cash Received
Worth noting, as mentioned in the ann, cash in this quarter,...
Featured News
Add VR1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.004(17.4%) |
Mkt cap ! $35.81M |
Open | High | Low | Value | Volume |
2.5¢ | 2.9¢ | 2.4¢ | $483.8K | 18.53M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 3518698 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 618600 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 3518698 | 0.027 |
6 | 3423432 | 0.026 |
4 | 2206200 | 0.025 |
2 | 2167866 | 0.024 |
4 | 1630434 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 600000 | 1 |
0.029 | 1438540 | 5 |
0.030 | 2027053 | 9 |
0.031 | 511870 | 5 |
0.032 | 468157 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
VR1 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online